What is the price target for Aphria?
The average twelve-month price target for Aphria is $22.75 with a high price target of $32.50 and a low price target of $15.00. Learn more Do Wall Street analysts like Aphria more than its competitors? Analysts like Aphria stock less than the stock of other Medical companies.
Does Aphria's (APH) stock have much upside?
Does Aphria's stock price have much upside? According to analysts, Aphria's stock has a predicted upside of 44.44% based on their 12-month price targets. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks.
Is Aphria efficiently growing its dividend?
Aphria does not have a long track record of dividend growth. In the past three months, Aphria insiders have not sold or bought any company stock. Only 10.30% of the stock of Aphria is held by institutions. Earnings for Aphria are expected to grow in the coming year, from ($0.06) to $0.07 per share.
How much of Aphria's stock is held by institutions?
Only 10.30% of the stock of Aphria is held by institutions. Earnings for Aphria are expected to grow in the coming year, from ($0.06) to $0.07 per share.
See more
Is APHA a buy or sell?
A P/B of 1 means it's selling at its per share book value....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return1Strong Buy24.75%2Buy18.15%3Hold9.70%4Sell5.35%2 more rows
What is the target price for APHA?
Historical Aphria Price Targets and RatingsDateBrokeragePrice Target4/16/2020Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating$5.00 ➝ $7.001/20/2020Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating$10.309 more rows
What happens to my Canadian Aphria stock after merger?
What will happen to Aphria once the arrangement is completed? Once completed, Tilray will acquire all outstanding Aphria Shares and Aphria will become a wholly-owned subsidiary of Tilray. Aphria Shares will be delisted from the TSX and NASDAQ.
Is APHA merger with Tilray?
After Tilray's (TLRY) shareholders voted in favor of the proposed merger Aphria (APHA) last Friday, the two cannabis companies announced today the completion of the transaction.
What was Aphria ticker symbol?
APHAAphria Inc. (APHA) Stock Price, News & Info | The Motley Fool.
When did Tilray acquire Aphria?
On December 16, 2020, Aphria Inc. (“Aphria”) announced that it had entered into a definitive agreement with Tilray, Inc. (“Tilray”) pursuant to which Tilray will acquire all the issued and outstanding shares of Aphria by way of a plan of arrangement under the Business Corporations Act (Ontario) (the “Transaction”).
Who purchased Aphria?
TilrayIrwin D Simon, formerly Aphria's CEO and chairman, will lead the new Tilray, with Tilray's current CEO Brendan Kennedy joining the board. Tilray shareholders voted in favor of the deal on Friday. Aphria shareholders received 0.8381 of a Tilray share for each Aphria common share owned.
What is Aphria called now?
TilrayLast week, Tilray (TLRY) and Aphria formally merged to form a new company. It instantly became the industry leader in the Canadian pot market.
What brands does Aphria own?
Aphria offers multiple products under a portfolio of recreational cannabis brands, including Good Supply, B! NGO, Solei, RIFF, and Broken Coast. In November 2020, Aphria acquired SweetWater Brewing Company, one of the largest craft breweries in the USA.
Why is Tilray closing?
The company says in an email that it is closing the facilities to optimize operational efficiencies and save costs following the merger.
What happens to Tilray stock after merger?
Under terms of the merger deal, Aphria shareholders will receive 0.8381 Tilray shares for each Aphria share they own, while Tilray shareholders will see no adjustment to their holdings. The "reverse acquisition" of Tilray represents a 23% premium to Tilray's stock closing price of $7.87 on Tuesday.
Who is Tilray merger with?
AphriaOnce-rival cannabis producers Tilray and Aphria completed their megamerger, the new company announced Monday, forming one of the biggest diversified marijuana, hemp and beer companies in the world.
How were Aphria's earnings last quarter?
Aphria Inc. (NASDAQ:APHA) released its earnings results on Sunday, April, 11th. The company reported ($1.14) earnings per share (EPS) for the quart...
Who are Aphria's key executives?
Aphria's management team includes the following people: Mr. Irwin D. Simon , CEO & Chairman (Age 62, Pay $5.23M) Mr. Carl A. Merton , Chief Fin...
Who are some of Aphria's key competitors?
Some companies that are related to Aphria include STADA Arzneimittel Aktiengesellschaft (STDAF) , Tilray (TLRY) , Canopy Growth (CGC) , USANA H...
What other stocks do shareholders of Aphria own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include AbbVie (ABBV) , Alibaba Grou...
What is Aphria's stock symbol?
Aphria trades on the NASDAQ under the ticker symbol "APHA."
What is Aphria's stock price today?
One share of APHA stock can currently be purchased for approximately $15.38.
How much money does Aphria make?
Aphria (NASDAQ:APHA) has a market capitalization of $4.87 billion and generates $405.96 million in revenue each year. The company earns $-63.21 mil...
How many employees does Aphria have?
Aphria employs 1,200 workers across the globe.
What is Aphria's official website?
The official website for Aphria is aphriainc.com .
Barchart Technical Opinion
The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.
Business Summary
Aphria Inc. produces, supplies and sells medical cannabis primarily in Canada. The company offers sativa, indica and hybrid medical marijuana products, as well as cannabis oils. Aphria Inc. is headquartered in Leamington, Canada.
Aphria (NASDAQ:APHA) Price Target and Consensus Rating
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy).
Analyst Price Target Consensus
Sign-up to receive the latest news and ratings for APHA and its competitors with MarketBeat's FREE daily newsletter.
Analyst Ratings By Month
The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Average Share Price and Price Target by Month
The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target.
Aphria (NASDAQ:APHA) Analyst Ratings Frequently Asked Questions
According to the issued ratings of 5 analysts in the last year, the consensus rating for Aphria stock is Hold based on the current 3 hold ratings and 2 buy ratings for APHA. The average twelve-month price target for Aphria is $22.25 with a high price target of $26.00 and a low price target of $18.00. Learn more on APHA's analyst rating history
